Upon retiring from the navy, Mr. Liang worked in several pharmaceutical corporations as senior technology officer and specialized in plant extract, medicine analysis and agricultural product processing. Mr. Liang owns several of his own formulas that specifically treat pain disease, diabetes, gout and tumor.
In addition, Mr. Liang also holds patent on natural and organic tea saponin cleaner and its recipe with State Intellectual Property Office of the P.R.C and the patent number is 201510938973.4.
"Mr. Liang is a seasoned businessman with in-depth understanding of traditional Chinese medicine, as well as modern medical technology," said Michael Palethorpe, President of Lotus. "It is my pleasure to work with Mr. Liang and his extensive knowledge and experience in both traditional Chinese medicine and pharmaceutical industry is extremely valuable to our cooperation. As strategic partners, Lotus and HC will collaborate and jointly promote our premium organic product and introduce to more families in China and worldwide"
About Lotus Bio-Technology Development Corp. Lotus Bio-Technology is an Arizona based bio-technology development company that specializes in the refining of organic materials and the production of natural consumer related products. The Company has the rights to farmland in China of 1,000 hectares, which are approximately 100 football fields combined. Our mandate is to grow various plants under strict organic standards and produce organic based consumer related products which completely are natural. The products will strike a balance between affordability and produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones or other dangerous chemicals while ensuring a solid financial return for our shareholders. The Company is a publicly traded company having its common shares quoted on the OTC Markets under the symbol LBTD.
Cautionary Note Regarding Forward-Looking Statements: This news release contains forward-looking statements about our business or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.
For more information please visit: www.lotusbiotechnologies.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lotus-bio-technology-development-corp-introduces-strategic-partner-president-300346541.html
SOURCE Lotus Bio-Technology Development Corp.